Consciousness Energy Healing Treatment and Its Impact on Physicochemical and Thermal Properties of Vanadium Pentoxide

Consciousness Energy Healing Treatment and Its Impact on Physicochemical and Thermal Properties of Vanadium Pentoxide

Alice Branton¹, Mahendra Kumar Trivedi¹, Dahryn Trivedi¹, Gopal Nayak¹, Snehasis Jana^2*

¹Trivedi Global, Inc., Henderson, USA
²Trivedi Science Research Laboratory Pvt. Ltd., Thane (W), India

Received Date: 25 September, 2019; Accepted Date: 30 September, 2019; Published Date: 09 October, 2019
^*Corresponding author: Snehasis Jana, Trivedi Science Research Laboratory Pvt. Ltd., Thane (W), Maharashtra, India. Tel: +9102225811234; Email: publication@trivedieffect.com

Citation: Branton A, Trivedi MK, Trivedi D, Nayak G, Jana S (2019) Consciousness Energy Healing Treatment and Its Impact on Physicochemical and Thermal Properties of Vanadium Pentoxide. Int Jr Pharma Scie and Chem: IJPSAC-109.

Abstract
Vanadium pentoxide (V₂O₅) is a brown/yellow inorganic compound, which has many industrial applications. The objective of this study was to evaluate the impact of the Trivedi Effect^®on the physicochemical and thermal properties of V₂O₅powder using sophisticated analytical techniques. V₂O₅powder sample was divided into two parts, one part of V₂O₅was considered as control (no Biofield Energy Treatment was provided), while second part received the Trivedi Effect^®-Consciousness Energy Healing Treatment remotely by a famous Biofield Energy Healer, Alice Branton and termed as a Biofield Energy Treated sample. The powder XRD analysis exhibited that the peak intensities of the treated V₂O₅were significantly altered ranging from -44.76% to 18.81% compared to the control sample. Similarly, the crystallite sizes of the treated sample were significantly altered ranging from -65.46% to 172.46% compared to the control sample. However, the average crystallite size of the treated sample was significantly increased by 18.08% compared with the control sample. The particle size values in the treated V₂O₅ were significantly increased by 10.21% (d₁₀), 27.37% (d₅₀), 57.69% (d₉₀), and 42.88% {D (4,3)} compared to the control sample. Therefore, the specific surface area of treated V₂O₅powder (0.23 m²/g) was significantly decreased by 29.88% compared with the control sample (0.328 m²/g). The total weight loss was significantly reduced by 64.12%; therefore, the residual amount was significantly increased by 4.11% in the treated V₂O₅compared with the control sample. The maximum thermal degradation temperature (T_max) of the 1^st peak in the treated sample was significantly increased by 5.45%; whereas, it was decreased by 16.36% in the 2^nd peak compared with the control sample. The results concluded that the Trivedi Effect^®-Consciousness Energy Healing Treatment might lead to generate a new polymorphic form of V₂O₅which would improve the of powder flowability, appearance, thermal stability, and may reduce toxicity due to larger particle size and reduced surface area compared to the control sample. The Trivedi Effect Treated vanadium pentoxide would also be useful for the industrial applications due to high thermal stability, i.e., bolometers and microbolometer arrays for thermal imaging, redox batteries for energy storage, ethanol sensor, etc.

Keywords: Vanadium pentoxide, The Trivedi Effect^®, Consciousness Energy Healing Treatment, PXRD, Particle size, Weight loss

Introduction
Vanadium pentoxide (V₂O₅) is the brown/yellow inorganic compound. It has a high oxidation state; hence, it is both an amphoteric oxide and an oxidizing agent. V₂O₅is used for the production of ferrovanadium (an alloy of iron and vanadium), sulfuric acid, maleic anhydride, and phthalic anhydride. It is also used as a material detector in bolometers and microbolometer arrays for thermal imaging, redox batteries for energy storage, and ethanol sensor (in ppm levels) [1-3]. V₂O₅exhibits very toxic to humans, with an LD₅₀ of about 470 mg/kg. It forms vanadate (VO₃^-4) by hydrolysis of V₂O₅ at higher pH, which appears to inhibit enzymes that process phosphate (PO₄^3-) [4].

Physico-chemical properties of a material play a critical role in the manufacturing and other industrial purposes. Therefore, in this study, special attention was taken to improve the physicochemical parameters of V₂O₅. In this situation, it was experimentally proved that Biofield Energy Healing Treatment (i.e., the Trivedi Effect^®) has a significant impact on the physicochemical properties of many substances [5-7]. The Trivedi Effect^® is a natural and only scientifically proven phenomenon in which a person can harness this inherently intelligent energy and transmit it anywhere on the planet through the possible mediation of neutrinos [7]. A unique energy field exists surrounding the every living organism’s body known as Biofield Energy, which is infinite, para-dimensional electromagnetic field. Biofield based Energy Healing Therapies have been reported to have significant outcomes against various disease conditions [8]. The National Institute of Health/National Center for Complementary and Alternative Medicine (NIH/NCCAM) recommend and included the Energy therapy under the Complementary and Alternative Medicine (CAM) category that has been accepted by the most of the U.S. population with several advantages [9, 10]. Many scientific experiments were conducted to prove the impact of the Trivedi Effect^®-Consciousness Energy Healing Treatment on the non-living and living object(s). The Trivedi Effect^®was proved with significant outcome in field of organic chemistry, material science, nutraceuticals, pharmaceutical sciences, cell biology, microbiology, and agriculture science [11-24]. Therefore, this study was designed to determine the impact of the Trivedi Effect^®on the physicochemical, and thermal properties of V₂O₅powder using powder X-ray diffraction (PXRD) particle size analysis (PSA), and thermal gravimetric analysis (TGA) / differential thermogravimetric analysis (DTG).

Materials and Methods
Chemicals and Reagents

The test sample vanadium pentoxide (V₂O₅) powder was purchased from Sigma-Aldrich, India. Rest of the chemicals used during the experiments was of analytical grade also purchased in India.

Consciousness Energy Healing Treatment Strategies

The V₂O₅powder sample in this experiment was divided into two parts. One part of the powder sample was termed as a control sample, which did not receive the Biofield Energy Treatment. However, the second part of V₂O₅powder was exposed to the Trivedi Effect^®-Energy of Consciousness Healing Treatment remotely under standard laboratory conditions for 3 minutes and known as the Biofield Energy Treated V₂O₅sample. This Biofield Energy Treatment was provided by the renowned Biofield Energy Healer, Alice Branton, USA, to the test sample. Further, the control sample was treated with a “sham” healer who did not have any knowledge about the Biofield Energy Treatment. After that, both the samples were kept in sealed conditions and characterized using PXRD, PSA, and TGA/DTG techniques.

Characterization

The powder XRD analysis of V₂O₅ samples was performed with the help of Rigaku Mini Flex-II Desktop X-ray diffractometer (Japan) [25, 26]. The average crystallite size was calculated from PXRD data using the Scherrer’s formula (1)

G = kλ/βcosθ (1)

Where G = crystallite size (nm), k = equipment constant, λ = radiation wavelength, β = full-width at half maximum, and θ = Bragg angle [27].

Similarly, the particle size analysis of V₂O₅ test samples was performed with the help of Malvern Mastersizer 2000 (UK) using the wet method [28, 29].

The % change in crystallite size, peak intensity, particle size, and specific surface area (SSC) of the Biofield Energy Treated V₂O₅was calculated compared with the control sample using the following equation 2:

Results and Discussion
Powder X-ray Diffraction (PXRD) Analysis

The PXRD diffractograms of both the V₂O₅powder showed sharp and intense peaks (Figure 1) indicated that both the samples were crystalline. The PXRD diffractograms of both the samples showed the highest peak intensity at 2θ equal to 26.2° (Table 1, entry 4). Overall the peak intensities of the Biofield Energy Treated V₂O₅ were significantly altered ranging from -44.76% to 18.81% compared to the control sample (Table 1), entry 1-23). The crystallite sizes of the treated V₂O₅ were significantly altered ranging from -65.46% to 172.46% compared to the control sample. However, the average crystallite size of the treated V₂O₅ was significantly increased by 18.08% compared with the control sample.

Figure 1: PXRD diffractograms of the control and Biofield Energy Treated V₂O₅.

Entry No.	Bragg angle (°2q)		Peak Intensity (%)			Crystallite size (G, nm)
Entry No.	Control	Treated	Control	Treated	% Change ^*	Control	Treated	% Change ^*
1	15.37	15.41	84.00	74.00	-11.90	488.00	491.00	0.61
2	20.27	20.35	297.00	279.00	-6.06	501.00	454.00	-9.38
3	21.69	21.78	84.00	77.00	-8.33	546.00	475.00	-13.00
4	26.12	26.18	166.00	145.00	-12.65	604.00	625.00	3.48
5	30.98	31.05	148.00	144.00	-2.70	462.00	466.00	0.87
6	32.36	32.43	59.00	56.20	-4.75	464.00	530.00	14.22
7	33.32	33.35	19.60	14.60	-25.51	503.00	600.00	19.28
8	34.28	34.32	61.40	54.80	-10.75	610.00	634.00	3.93
9	41.21	41.26	46.10	36.90	-19.96	433.00	575.00	32.79
10	45.45	45.49	29.10	23.90	-17.87	578.00	940.00	62.63
11	47.30	47.37	48.00	41.90	-12.71	573.00	687.00	19.90
12	47.82	47.85	28.00	23.60	-15.71	538.00	648.00	20.45
13	48.82	48.82	27.10	22.90	-15.50	558.00	600.00	7.53
14	51.18	51.21	49.30	45.00	-8.72	592.00	606.00	2.36
15	55.60	55.67	21.70	14.40	-33.64	488.00	1032.00	111.48
16	59.00	59.01	27.00	15.10	-44.07	456.00	605.00	32.68
17	61.05	61.15	27.00	21.90	-18.89	654.00	586.00	-10.40
18	62.06	62.11	29.20	26.70	-8.56	616.00	665.00	7.95
19	64.40	64.41	14.30	7.90	-44.76	209.00	279.00	33.49
20	69.64	69.78	10.10	12.00	18.81	469.00	162.00	-65.46
21	70.29	70.38	11.40	7.90	-30.70	523.00	838.00	60.23
22	72.61	72.69	35.00	20.00	-42.86	138.00	376.00	172.46
23	Average crystallite size					496.04	585.74	18.08
^*denotes the percentage change in the peak intensity and crystallite size of treated sample with respect to the control sample.

Table 1: PXRD data for the control and Biofield Energy Treated V₂O₅.

The variations in the crystallite sizes and peak intensities significantly alter the crystal morphology of the sample. The peak intensity of each diffraction face on the crystalline compound changes according to the crystal morphology [30], and alterations in the PXRD pattern provide the proof of polymorphic transitions [31, 32]. Therefore, it was assumed that a new polymorphic form of V₂O₅ might have produced due to Trivedi Effect^®-Consciousness Energy Healing Treatment probably via the mediation of neutrino oscillation [7]. Different polymorphic forms of a crystal have the significant effects on the thermodynamic and physicochemical properties like melting point, energy, stability, and especially solubility, which are different from the original form [33, 34]. Thus, it can be assumed that the treated V₂O₅ would be better for industrial applications.

Particle Size Analysis (PSA)

The particle size distribution analysis of both the control and Biofield Energy Treated V₂O₅powder was performed, and the data are presented in (Table 2). The particle size values of the control V₂O₅ at d₁₀, d₅₀, d₉₀, and D (4, were 13.72 µm, 40.84 µm, 131.83 µm, and 59.53 µm, respectively. Similarly, the particle sizes of the Biofield Energy Treated V₂O₅ at d₁₀, d₅₀, d₉₀, and D (4, 3) were 15.13 µm, 52.02 µm, 207.89 µm, and 85.06 µm, respectively. The particle size values in the Biofield Energy Treated V₂O₅ were significantly increased at d₁₀, d₅₀, d₉₀, and D (4, 3) by 10.21%, 27.37%, 57.69%, and 42.88 %, respectively compared to the control sample. Therefore, the specific surface area of Biofield Energy Treated V₂O₅powder (0.23 m²/g) was significantly decreased by 29.88% compared with the control sample (0.328 m²/g). As per the results, it can be assumed that the Trivedi Effect^®-Consciousness Energy Healing Treatment might be acting as external energy for increasing the particle size and hence decreased the surface area of V₂O₅powder compared to the control sample. Incising the particle size of pharmaceutical compounds decrease the surface area and decrease the solubility, dissolution rate, and bioavailability in the physiological system [35]. As V₂O₅is very toxic to humans [3], reduction of the surface area of Biofield Energy Treated sample would be less toxic compared to the control sample. The treated V₂O₅ would be better flow ability and appearance compared to the control sample, which would be beneficial for the industrial applications.

Parameter	d₁₀(µm)	d₅₀(µm)	d₉₀(µm)	D(4,3)(µm)	SSA(m²/g)
Control	13.72	40.84	131.83	59.53	0.328
Biofield Energy Treated	15.13	52.02	207.89	85.06	0.23
Percent change^* (%)	10.21	27.37	57.69	42.88	-29.88
d_10,d₅₀, and d₉₀: particle diameter corresponding to 10%_, 50%_, and 90% of the cumulative distribution, D (4, 3): the average mass-volume diameter, and SSA: the specific surface area. ^*denotes the percentage change in the Particle size distribution of the treated sample with respect to the control sample.

Table 2: The particle size distribution of the control and Biofield Energy treated V₂O₅.

Thermal Gravimetric Analysis (TGA)/ Differential Thermogravimetric Analysis (DTG)

The TGA thermograms of the control and Biofield Energy Treated V₂O₅samples showed one step of thermal degradation (Figure 2). The total weight loss in the Biofield Energy Treated V₂O₅was significantly decreased by 64.12% compared with the control sample (Table 3). Therefore, the residue amount was increased by 4.11% in the Biofield Energy Treated V₂O₅compared to the control sample (Table 3).

Figure 2: TGA thermograms of the control and Biofield Energy Treated V₂O₅.

Sample	TGA		DTG; T_max (°C)
Sample	Total weight loss (%)	Residue %	1^st Peak	2^nd Peak
Control	6.02	93.98	314.82	775.54
Biofield Energy Treated	2.16	97.84	346.8	648.64
% Change^*	-64.12	4.11	10.16	-16.36
^*denotes the percentage change of the treated sample with respect to the control sample, T_max = the temperature at which maximum weight loss takes place in TG or peak temperature in DTG.

Table 3: TGA/DTG data of the control and Biofield Energy Treated samples of V₂O₅.

Figure 3: DTG thermograms of the control and Biofield Energy Treated V₂O₅.

The DTG thermogram of the control and Biofield Energy Treated V₂O₅sample exhibited two peaks (Figure 3). The maximum thermal degradation temperature (T_max) of the 1^st peak in the Biofield Energy Treated sample was significantly increased by 5.45%, whereas it was decreased by 16.36% in the 2^nd peak compared with the control sample (Table 3). Overall, TGA/DTG revealed that the thermal stability of the Biofield Energy Treated V₂O₅was significantly increased compared with the control sample. This elevation in the thermal stability would be useful for industrial applications, i.e., thermal imaging, ethanol sensor, redox batteries for energy storage, etc.

Conclusions
The Trivedi Effect^®-Consciousness Energy Healing Treatment showed significant effects on the physico-chemical properties of the V₂O₅ powder. The PXRD analysis exhibited that the peak intensities of the Biofield Energy Treated V₂O₅were significantly altered ranging from -44.76% to 18.81% compared to the control sample. Similarly, the crystallite sizes of the Biofield Energy Treated sample were significantly altered ranging from -65.46% to 172.46% compared to the control sample. However, the average crystallite size of the Biofield Energy Treated sample was significantly increased by 18.08% compared with the control sample. The particle size values in the Biofield Energy Treated V₂O₅ were significantly increased at d₁₀, d₅₀, d₉₀, and D (4, 3) by 10.21%, 27.37%, 57.69%, and 42.88%, respectively compared to the control sample. Therefore, the specific surface area of Biofield Energy Treated V₂O₅powder (0.23 m²/g) was significantly decreased by 29.88% compared with the control sample (0.328 m²/g). The total weight loss was significantly reduced by 64.12%; therefore, the residual amount was significantly increased by 4.11% in the Biofield Energy Treated V₂O₅compared with the control sample. The T_max of the 1^st peak in the Biofield Energy Treated sample was significantly increased by 5.45%, whereas it was decreased by 16.36% in the 2^nd peak compared with the control sample. The results concluded that the Trivedi Effect^®-Consciousness Energy Healing Treatment might lead to generate a new polymorphic form of V₂O₅which would improve the of powder flowability, appearance, thermal stability, and may reduce toxicity due to larger particle size and reduced surface area compared to the control sample. The Trivedi Effect Treated V₂O₅ would also be useful for the industrial applications due to high thermal stability, i.e., bolometers and microbolometer arrays for thermal imaging, ethanol sensor, redox batteries for energy storage, etc.

Acknowledgements
The authors are grateful to Central Leather Research Institute, SIPRA Lab. Ltd., Trivedi Science, Trivedi Global, Inc., Trivedi Testimonials, and Trivedi Master Wellness for their assistance and support during this work.

References

https://en.wikipedia.org/wiki/Vanadium(V)_oxide. Retrieved 05 March, 2019.
Norman NG, Alan E (1984) Chemistry of the Elements. Oxford: Pergamon Press. pp. 1140, 1144.
Bauer G, Güther V, Hess H, Otto A, Roidl O, et al. (2005) Vanadium and Vanadium Compounds. Ullmann's Encyclopedia of Industrial Chemistry, Wiley-VCH, Weinheim.
Trivedi MK, Tallapragada RM (2008) A transcendental to changing metal powder characteristics. Metal Powder Report 63: 22-28, 31.
Trivedi MK, Tallapragada RM (2009) Effect of superconsciousness external energy on the atomic, crystalline and powder characterisitics of “carbon allotrope powders”. Materials Research Innovations 13: 473-480.
Trivedi MK, Patil S, Tallapragada RM (2015) Effect of biofield treatment on the physical and thermal characteristics of Silicon, Tin and Lead powders. J Material Sci Eng 2:125.
Trivedi MK, Mohan TRR (2016) Biofield energy signals, energy transmission and neutrinos. American Journal of Modern Physics 5: 172-176.
Rubik B, Muehsam D, Hammerschlag R, Jain S (2015) Biofield science and healing: History, terminology, and concepts. Glob Adv Health Med 4: 8-14.
Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 12: 1-23.
Koithan M (2009) Introducing complementary and alternative therapies. J Nurse Pract 5: 18-20.
Trivedi MK, Branton A, Trivedi D, Nayak G, Bairwa K, et al. (2015) Physical, thermal and spectroscopical characterization of biofield treated triphenylmethane: An Impact of biofield treatment. J Chromatogr Sep Tech 6: 292.
Trivedi MK, Branton A, Trivedi D, Nayak G, Bairwa K, et al. (2015) Fourier Transform infrared and ultraviolet-visible spectroscopic characterization of ammonium acetate and ammonium chloride: An impact of biofield treatment. Mod Chem appl 3:163.
Trivedi MK, Nayak G, Patil S, Tallapragada RM, Latiyal O, et al. (2015) Studies of the atomic and crystalline characteristics of ceramic oxide nano powders after biofield treatment. Ind Eng Manage 4: 161.
Trivedi MK, Patil S, Nayak G, Jana S, Latiyal O (2015) Influence of biofield treatment on physical, structural and spectral properties of boron nitride. J Material Sci Eng 4: 181.
Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, et al. (2015) Evaluation of biofield energy treatment on physical and thermal characteristics of selenium powder. Journal of Food and Nutrition Sciences 3: 223-228.
Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, et al. (2015) Potential impact of biofield treatment on atomic and physical characteristics of magnesium. Vitam Miner 3: 129.
Trivedi MK, Branton A, Trivedi D, Nayak G, Bairwa K, et al. (2015) Spectroscopic characterization of disulfiram and nicotinic acid after biofield treatment. J Anal Bioanal Tech 6: 265.
Trivedi MK, Branton A, Trivedi D, Shettigar H, Bairwa K, et al. (2015) Fourier transform infrared and ultraviolet-visible spectroscopic characterization of biofield treated salicylic acid and sparfloxacin. Nat Prod Chem Res 3:186.
Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) In vitro evaluation of Biofield treatment on cancer biomarkers involved in endometrial and prostate cancer cell lines. J Cancer Sci Ther 7: 253-257.
Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) The potential impact of biofield treatment on human brain tumor cells: A time-lapse video microscopy. J Integr Oncol 4: 141.
Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) An impact of biofield treatment: Antimycobacterial susceptibility potential using BACTEC 460/MGIT-TB system. Mycobact Dis 5: 189.
Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, et al. (2015) Antibiogram, biochemical reactions and biotyping of biofield treated Providencia rettgeri. American Journal of Health Research 3: 344-351.
Trivedi MK, Branton A, Trivedi D, Nayak G, Gangwar M, et al. (2015) Agronomic characteristics, growth analysis, and yield response of biofield treated mustard, cowpea, horse gram, and groundnuts. International Journal of Genetics and Genomics 3: 74-80.
Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, et al. (2015) Evaluation of plant growth, yield and yield attributes of biofield energy treated mustard (Brassica juncea) and chick pea (Cicer arietinum) Agriculture, Forestry and Fisheries 4: 291-295.
Desktop X-ray Diffractometer “MiniFlex+”. The Rigaku Journal 14: 29-36, 1997.
Zhang T, Paluch K, Scalabrino G, Frankish N, Healy AM, Sheridan H (2015) Molecular structure studies of (1S,2S)-2-benzyl-2,3-dihydro-2-(1Hinden-2-yl)-1H-inden-1-ol. J Mol Struct 1083: 286-299.
Langford JI, Wilson AJC (1978) Scherrer after sixty years: A survey and some new results in the determination of crystallite size. J Appl Cryst 11: 102-113.
Trivedi MK, Sethi KK, Panda P, Jana S (2017) A comprehensive physicochemical, thermal, and spectroscopic characterization of zinc (II) chloride using X‑ray diffraction, particle size distribution, differential scanning calorimetry, thermogravimetric analysis/differential thermogravimetric analysis, ultraviolet‑visible, and Fourier transform-infrared spectroscopy. International Journal of Pharmaceutical Investigation 7: 33-40.
Trivedi MK, Sethi KK, Panda P, Jana S (2017) Physicochemical, thermal and spectroscopic characterization of sodium selenate using XRD, PSD, DSC, TGA/DTG, UV-vis, and FT-IR. Marmara Pharmaceutical Journal 21/2: 311-318.
Inoue M, Hirasawa I (2013) The relationship between crystal morphology and XRD peak intensity on CaSO₄.2H₂ J Crystal Growth 380: 169-175.
Raza K, Kumar P, Ratan S, Malik R, Arora S (2014) Polymorphism: The phenomenon affecting the performance of drugs. SOJ Pharm Pharm Sci 1: 10.
Brittain HG (2009) Polymorphism in pharmaceutical solids in Drugs and Pharmaceutical Sciences, volume 192, 2^nd Edn, Informa Healthcare USA, Inc., New York.
Censi R, Martino PD (2015) Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs. Molecules 20: 18759-18776.
Blagden N, de Matas M, Gavan PT, York P (2007) Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 59: 617-630.
Chereson R (2009) Bioavailability, bioequivalence, and drug selection. In: Makoid CM, Vuchetich PJ, Banakar UV (Eds) Basic pharmacokinetics (1^st Edn) Pharmaceutical Press, London.